BRS BIODEGRADABE POLYMERS BIOADAPTORS | IS THERE A FUTURE FOR THE TECHNOLOGY?

Sunday, February 26, 2023

3:50 PM – 5:18 PM ET

Moderator(s)

Alexandre A. Abizaid, MD, PhD

Director of Invasive Cardiology
Incor
SÃO PAULO, Sao Paulo, Brazil

Disclosure(s): Boston Scientific: Proctor (Ongoing); Elixir Medical: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Ricardo A. Costa, MD, PhD

Interventional Cardiologist - Percutaneous Intervention Research Medical Section Chief
Institute Dante Pazzanese of Cardiology
Sao Paulo, Sao Paulo, Brazil

Disclosure(s): No financial relationships to disclose
Yoshinobu Onuma, MD, PhD (he/him/his)

Professor of Interventional Cardiology
National University of Ireland, Galway
Galway, Galway, Ireland

Disclosure(s): No financial relationships to disclose
Michael H. Joner, MD

Associate Professor Interventional Cardiology
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)

Disclosure(s):

Alexandre A. Abizaid, MD, PhD: Boston Scientific: Proctor (Ongoing); Elixir Medical: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Ricardo A. Costa, MD, PhD: No financial relationships to disclose

Yoshinobu Onuma, MD, PhD: No financial relationships to disclose

Michael H. Joner, MD: Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)